Researchers in Cape Town are starting local clinical trials of a Covid-19 vaccine designed to protect people from infection caused by variants of the coronavirus, now and in the future.The vaccine was developed by California-based biotechnology companies ImmunityBio and NantKwest. It targets both a protein known as a nucleocapsid, which coronaviruses use to infect their host, and the so-called spike protein zeroed in on by vaccines authorized for use already.Scientists leading the trial say the nucleocapsid may be less likely to mutate than the spike protein, which since the start of the pandemic has changed in ways that lower the protection provided by vaccines that target the spike alone.
Hence then, the article about cape town is testing a covid 19 vaccine designed to protect against new variants was published today ( ) and is available onQuartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Cape Town is testing a Covid-19 vaccine designed to protect against new variants )